A new approach to Crohn’s disease is based on genetic analysis of the immune response. The genetic analysis reveals that altering the activity of a specific immune regulator subtly dampens the immune response, offering potential relief for those suffering from Crohn’s disease. A new drug, compound 6, does just that. Clinical trials are currently underway. […]
